The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, Illinois, has agreed to pay $3.6 million to resolve claims that Assertio violated the False Claims Act (FCA) by causing the submission of false claims for the transmucosal immediate-release fentanyl (TIRF) Read More
Home » Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Related Posts
U.S. Trustee Program Obtains More Than $1.1M in Monetary Relief
The Justice Department’s U.S. Trustee Program (USTP) obtained a judgment imposing more than $1.1 million in civil penalties, fines, damages, and fees against 12 defendants… BronU.S. Trustee Program Obtains More Than $1.1M in Monetary Relief
Eight MS-13 Gang Members Plead Guilty to Multi-Year Racketeering
Eight members of the violent transnational criminal organization Mara Salvatrucha, commonly known as MS-13, pleaded guilty today to charges stemming from a multi-year racketeering conspiracy… BronEight MS-13 Gang Members Plead Guilty to Multi-Year Racketeering
California Man Sentenced for Role in Global Digital Asset Investment
A California man was sentenced today to 51 months in federal prison for his role in laundering more than $36.9 million from victims in an… BronCalifornia Man Sentenced for Role in Global Digital Asset Investment